In contrast, the APC mutant and KRAS WT COLO320DM colorectal cancer cell line did not reduce growth or change canonical WNT activity upon treatment with the MEKi, neither alone or in combination with the TNKSi. The gene discussed is KRAS; the disease is colorectal cancer.